GCDFP-15 blood levels for stratification of risk of breast cancer development in women with active breast gross cystic disease

Breast

Volumn 6, Issue 3, 1997, Pages 113-119

  Haagensen, D E ^a,b,d   Kelly, D ^b   Bodian, C A ^b,c  

^a NEW YORK METHODIST HOSPITAL   (United States)

^b Haagensen Research Foundation Inc   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

^d RESOURCE Foundation Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN;

APOCRINE GLAND; ARTICLE; ASPIRATION; BREAST CANCER; BREAST CARCINOMA; BREAST CYST; CANCER RISK; CLINICAL ARTICLE; CYST FLUID; FEMALE; HUMAN; METAPLASIA; METASTASIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0030976113     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(97)90550-6     Document Type: Article

References (46)

1. Haagensen C D. Diseases of the Breast. 3rd edn. Philadelphia: WB Saunders, 1986: 250-266.
2. Wellings S R, Alpers C E. Apocrine cystic metaplasia: subgross pathology and prevalence in cancer associated versus random autopsy breasts. Hum Path 1987; 18: 381-386.
3. Jones B M, Bradbeer J W. The presentation and progress of macroscopic breast cysts. Brit J Surg 1980; 67: 669-671.
4. Harrington E, Lesnick G. The association between gross cysts of the breast and breast cancer. Breast 1980; 7: 13-17.
5. Ciatto S, Biggeri A, Del Turco M R, Bartoli D, Iossa A. Risk of breast cancer subsequent to proven gross cystic disease. Eur J Cancer 1990; 26: 555-557.
6. Bundred N J, West R R, O'Dowd J, Mansel R E, Hughes L E. Is there an increased risk of breast cancer in women who have had a breast cyst aspirated? Brit J Cancer 1991; 64: 953-955.
7. Bodian C A, Lattes R, Perzin K H. The epidemiology of gross cystic disease of the breast confirmed by biopsy or by aspiration of cyst fluid. Cancer Det Prev 1992; 16: 7-15.
8. Haagensen D E Jr, Mazoujian G M, Dilley W G, Pedersen C E, Kister S J, Wells S A Jr. Breast gross cystic disease fluid analysis. I. Isolation and radioimmunoassay for a major component protein. J Natl Cancer Inst 1979; 62: 239-247.
9. Haagensen D E Jr, Mazoujian G. Biochemistry and immunochemistry of gross cystic disease fluid proteins of the breast. In: Haagensen C D (ed): Diseases of the Breast. 3rd edn. Philadelphia: W B Saunders, 1986; 474-500.
10. Bradlow H L, Rosenfeld R S, Kream J, Fleisher M, O'Connor J, Schwartz M K. Steroid hormone accumulation in human breast cyst fluid. Cancer Res 1981; 41: 105-107.
11. Miller W R, Roberts M M, Creel R J, Yap P L, Kelly R W, Forrest APM. Androgen conjugates in human breast cyst fluids. J Natl Cancer Inst 1982; 69: 1055-1058.
12. Vanluchene E, Vandekerckhove D, De Boever J, Sandra P. Structures and concentrations of fifteen different steroid sulfates in human breast cyst fluids. J Steroid Biochem 1984; 21: 367-371.
13. Belanger A, Caron S, Labrie F, Naldoni C, Dogliotti L, Angeli A. Levels of eighteen non-conjugated and conjugated steroids in human breast cyst fluid: relation to cyst type. Eur J Cancer 1990; 26: 277-281.
14. Pearlman W H, Gueriguian J L, Sawyer M E. A specific progesterone-binding component of human breast cyst fluid. J Biol Chem 1973; 248: 5736-5741.
15. Lea O A. Binding properties of progesterone-binding cyst protein PBCP. Steroids 1988; 52: 333-338.
16. Balbin M, Freije J M P, Fueyo A, Sanchez L M, Lopez-Otin C. Apolipoprotein D is the major component protein in cyst fluid from women with human breast gross cystic disease. Biochem J 1990; 271: 803-807.
17. Sanchez L M, Diez-Itza I, Vizoso F, Lopez-Otin C. Cholesterol and apolipoprotein D in gross cystic disease of the breast. Clin Chem 1992; 38: 695-698.
18. Miller W R, Scott W N, Harris W H, Wang D. Using biological measurements, can patients with benign breast disease who are at high risk for breast cancer be identified. Cancer Det Prev 1992; 16: 99-106.
19. Kesner L M, Yu W, Bradlow H L, Breed C W, Fleisher M. Proteases in cyst fluids from human gross cyst breast disease. Cancer Res 1988; 48: 6379-6383.
20. 4 and prolactin in human breast cyst fluid. Tumori 1982; 68: 393-396.
21. 4 and electrolyte concentrations. Int J Cancer 1989; 44: 229-232.
22. Takahaski K, Lai L C, Ghatei M A, James V H T, Bloom S R. Endothelin-like immunoreactivity in human breast cyst fluid. J Clin Endocrinol Metab 1990; 71: 1681-1683.
23. Collette J, Hendrick J C, Jaspar J M, Franchimont P. Presence of alpha lactalbumin, epidermal growth factor, epithelial membrane antigen and GCDFP-15 in breast cyst fluid. Cancer Res 1986; 46: 3728-3733.
24. Wang D Y, Hamed H, Fentiman I S. Epidermal growth factor and insulin-like growth factor-I in human breast cyst fluid. Ann N Y Acad Sci 1990; 586: 158-160.
25. Balbin M, Vizoso F, Sanchez L M, Venta R, Ruibal A, Fueyo A, Lopez-Otin C. GCDFP-70 protien in cyst fluid identified as albumin and used to classify cysts in women with breast gross cystic disease. Clin Chem 1991; 37: 547-551.
26. Scott W N, Miller W R. Mutagens in human breast cyst fluid. J Cancer Res Clin Oncol 1991; 117: 254-258.
27. Sanchez L M, Vizoso F, Allende M J, Ruibal A, Lopez-Otin C. Quantification and molecular analysis of cathepsin D in breast cyst fluids. Eu J Cancer 1992; 78: 828-832.
28. Lai L C, Ghatei M A, Takahashi K, Patel K V, Schrey M P, Ghilchik M W, Bloom S R, James V H T. Mitogenic peptides in breast cyst fluid: relationship with intracystic electrolye ratios. Int J Cancer 1990; 46: 1014-1016.
29. Haagensen D E Jr, Dilley W G, Mazoujian G, Wells S A Jr. Review of GCDFP-15, an apocrine marker protein. Ann N Y Acad Sci 1990; 586: 161-173.
30. Haagensen D E Jr, Wells S A Jr, Haider M. Analysis of human breast gross cystic diease fluid protein (GCDFP-15) by isotope dilution RIA with a solid phase (Kynar) second antibody (abstract). Proc Am Assoc Clin Chem 1980; 26: 980.
31. Freker P J, Speck J C. Protein and cell membrane iodination with a sparingly chloroamine, 1,3,4,6 tetra-chloro-3-alpha, 6-alpha, diphenylglycoluril. Biochem Biophys Res Comm 1978; 80: 849-857.
32. Newman E S, Moskie L A, Duggal R N, Goldenberg D M, Hansen H J. Murine monoclonal antibody absorbed onto vinylidene fluoride floccules used to eliminate antibody interference in sandwich type immunoassays. Clin Chem 1989; 35: 1743-1746.
33. Frantz V K, Pickren J W, Melcher G W, Auchincloss H. Incidence of chronic cystic breast disease in so-called "normal breast". Cancer 1951; 4: 762-783.
34. Haagensen D E Jr. Is cystic disease related to breast carcinoma? Am J Surg Path 1991; 15: 687-694.
35. Myal Y, Gregory C, Wang H, Hamerton J L, Shiu R P C. The gene for prolactin inducible protein, uniquely expressed in exocrine organs, Maps to Chromosome 7. Somatic and Mol Genetics 1989; 15: 256-270.
36. Myal Y, Robinson D B, Iwasiow B, Tsuyuki D, Wong P, Shiu R P C. The prolactin inducible protein (PIP/GCDFP-15) gene: cloning, structure and regulation. Mol Cell Endocrinol 1991; 80: 165-175.
37. Mazoujian G, Pinkus G S, Davis S, Haagensen D E Jr. Immunohistochemistry of a breast gross cystic disease fluid protein (GCDFP-15): a marker of aprocrine epithelium and breast carcinomas with apocrine features. Am J Pathol 1983; 110: 105-121.
38. Cassone P, Sapino A, Haagensen D E, Naldoni C, Bussolati G. Mitogenic effect of the gross cystic disease fluid protein of 15KD (GCDFP-15) on breast cancer cell lines and on immortalized mammary cells. Int J Cancer 1995; 60: 216-220.
39. Haagensen C D, Bodian C A, Haagensen D E Jr. Breast Carcinoma: Risk and Detection. Philadelphia: W B Saunders, 1981, 300-338.
40. Chalbos D, Haagensen D E Jr, Parish T, Rochefort H. Identification and androgen regulation of two proteins released by T47D human breast cancer cells. Cancer Res 1987; 47: 2787-2792.
41. Simard J, Hatton A C, Labrie C. Dauvois S, Zaho H F. Haagensen D E Jr, Labrie F. Inhibitory effects of estrogens on GCDFP-15 mRNA levels and secretion in ZR 75-1 human breast cancer cells. Mol Endocrinology 1989; 3: 694-702.
42. Dejardin L, Gol-Winkler R, Collette J, Delvenne C, Carlisi I, Haagensen D E, Franchimont P. Stimulatory Effect of estradiol and tamoxifen on gross cystic disease fluid protien 15000 production and mRNA levels in T47D human breast cancer cells. J Mol Endocrinology 1991; 7: 105-112.
43. Haagensen D E Jr, Stewart P, Dilley W G, Wells S A Jr. Secretion of breast gross cystic disease fluid proteins by T47D breast cancer cells in culture - modulation by steriod hormones. Br Cancer Res Treat 1992; 23: 77-86.
44. Dupont W D, Page D L. Risk factors for cancer in women with proliferative disease. New Eng J Med 1985; 312: 146-151.
45. Bodian C A. Benign breast diseases, carcinoma in situ and cancer risk: Epidemiological Reviews 1993; 15: 177-187.
46. Bodian C A, Perzin K H, Lattes R, Hoffman P, Abernathy T G. Prognostic significance of benign proliferative breast disease. Cancer 1993; 71: 3896-3907.